NCT02959255View on ClinicalTrials.gov

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

December 30, 2017

Study Completion Date

December 30, 2017

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

dosage difference

Trial Locations (1)

Unknown

Army Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY